MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Alphatec Holdings Market Cap 2011-2026 | ATEC
As of March 25, 2026 Alphatec Holdings has a market cap of $ 1.75 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.07 B | 1.55 B | 1.86 B | 1.52 B | 1.06 B | 1.08 B | 364 M | 54 M | 42.2 M | 25.3 M | 41.8 M | 125 M | 215 M | 153 M | 161 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.07 B | 25.3 M | 688 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Penumbra
PEN
|
13.2 B | $ 335.76 | 0.45 % | $ 13.1 B | USA |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 221.53 | -1.76 % | $ 15.6 B | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Profound Medical Corp.
PROF
|
230 M | $ 5.73 | 11.26 % | $ 180 M |  Canada |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Quanterix Corporation
QTRX
|
269 M | $ 4.0 | 4.71 % | $ 171 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
AVITA Medical
RCEL
|
104 M | $ 3.97 | 3.39 % | $ 111 M |  Australia |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.75 | 0.45 % | $ 1.14 B | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.6 | 1.17 % | $ 7.21 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
175 M | $ 24.89 | 0.77 % | $ 210 M | USA |
 |
Smith & Nephew plc
SNN
|
29.7 B | $ 32.38 | 0.67 % | $ 23.8 B |  Britain |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M | Canada |
 |
Sensus Healthcare
SRTS
|
72.3 M | $ 4.23 | 6.82 % | $ 69.1 M | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 4.13 | - | $ 610 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.69 | -1.55 % | $ 37.6 M | USA |
 |
Aethlon Medical
AEMD
|
3.03 M | $ 2.29 | 5.9 % | $ 3.57 M | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 27.7 | 3.13 % | $ 634 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
TELA Bio
TELA
|
131 M | $ 0.7 | -8.05 % | $ 16 M | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.82 | 0.81 % | $ 468 M |  Curacao |
 |
InspireMD
NSPR
|
115 M | $ 1.78 | -0.84 % | $ 114 M | Israel |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 24.17 | -1.41 % | $ 1.64 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.42 | -0.52 % | $ 1.54 B | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.7 | -0.27 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.33 | -3.13 % | $ 137 M | Israel |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 3.7 | -5.37 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.3 | 2.45 % | $ 382 M | USA |
 |
Outset Medical
OM
|
52.5 K | $ 3.48 | -1.45 % | $ 52.9 K | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 51.73 | -0.67 % | $ 1.52 B | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.3 | -1.15 % | $ 52.9 M | USA |